India’s emergence as a global pharmaceutical powerhouse is entering a new phase, driven by innovation, vaccine leadership, and expanding clinical capabilities, according to Dr Elias Zerhouni, former director of the US National Institutes of Health (NIH). "I've seen a growing relationship... we are not just working with India as a manufacturing hub, but also as an innovative partner", he said.